Filing Flows › Taysha Gene Therapies (TSHA) › How it makes money
How Taysha Gene Therapies (TSHA) makes money
Taysha Gene Therapies (TSHA) made $5.5M of revenue in the fourth quarter 2025 (Q4 2025), +171% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q4 2025 | % of revenue |
|---|---|---|
| Revenue | $5.5M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q4 2025 | $5.5M | +171% |
| Q2 2025 | $2.0M | +79% |
| Q1 2025 | $2.3M | -32% |
| Q4 2024 | $2.0M | -44% |
From Taysha Gene Therapies' 10-K filed Mar 19, 2026 (on EDGAR).
Questions
How does Taysha Gene Therapies make money?
Taysha Gene Therapies (TSHA) made $5.5M of revenue in the fourth quarter 2025 (Q4 2025), +171% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.